No vaccine has been shown to cause autism. A meta-analysis covering more than 1.25 million children found no relationship between vaccination and autism for any vaccine type, any ingredient, or any combination of doses. This is one of the most thoroughly studied questions in modern medicine, and the exposed data consistently point in the same direction: vaccines do not increase the risk of autism spectrum disorder.
What the Largest Studies Found
A 2014 meta-analysis combined data from five large cohort studies (1,256,407 children) and five case-control studies (9,920 children). It found no increased risk of autism associated with vaccination overall, with the MMR vaccine specifically, or with the mercury-based preservative thimerosal. The odds ratios were essentially 1.0 across the board, meaning vaccinated and unvaccinated children developed autism at the same rate.
One of the strongest individual studies tracked every child born in Denmark between 1991 and 1998, more than 500,000 children total, including nearly 100,000 who never received the MMR vaccine. Children who got the MMR vaccine were no more likely to develop autism than those who didn’t. If anything, the vaccinated group had a slightly lower rate, though the difference wasn’t statistically meaningful.
Perhaps the most telling evidence came from Japan. When Japan stopped using the MMR vaccine entirely in 1993, researchers tracked what happened to autism rates afterward. They continued to climb. If MMR caused autism, removing it from the population should have reversed the trend. It didn’t.
Why the MMR Vaccine Got Blamed
The vaccine-autism concern traces back to a 1998 paper by Andrew Wakefield, published in The Lancet, which suggested a link between the MMR vaccine and autism. The paper studied just 12 children. In 2010, The Lancet fully retracted it after an investigation by Britain’s General Medical Council found that Wakefield had carefully selected his subjects to support a predetermined conclusion, that some of his research was funded by lawyers representing parents suing vaccine manufacturers, and that he had not disclosed these conflicts of interest. The council found he had acted unethically and showed “callous disregard” for the children in his study, who underwent invasive procedures that were not clinically justified.
Despite the retraction, the paper had already shaped public perception. The idea that MMR causes autism became embedded in popular culture, and the studies disproving it, though far larger and more rigorous, have struggled to catch up.
The Thimerosal Question
Thimerosal is a mercury-containing preservative that was used in some childhood vaccines. It contains ethylmercury, which the body clears quickly, unlike the methylmercury found in certain fish that accumulates over time. Still, concerns about mercury exposure led to thimerosal being removed from childhood vaccines in the United States in 2001 as a precautionary measure.
That removal created a natural experiment. If thimerosal caused autism, rates should have dropped after 2001. They did not. Autism diagnoses continued to rise at the same pace. Today, all routine childhood vaccines in the U.S. are available in thimerosal-free formulations. The only vaccines that still contain it are certain multi-dose flu vaccine vials, and thimerosal-free flu vaccines are readily available as alternatives. MMR, chickenpox, polio, and pneumococcal vaccines never contained thimerosal.
Aluminum Adjuvants
Some vaccines contain tiny amounts of aluminum salts, which help strengthen the immune response. This has raised separate concerns about whether aluminum could affect brain development. The World Health Organization’s Global Advisory Committee on Vaccine Safety reviewed the FDA’s risk assessment and concluded that the total aluminum a child receives from vaccines never exceeds safe thresholds, even in low-birth-weight infants. For context, infants take in far more aluminum through breast milk and formula than they ever receive from vaccines. The committee found that studies claiming to link aluminum adjuvants to autism relied on incorrect assumptions and inaccurate data, limiting their usefulness even as a starting point for further research.
Multiple Vaccines at Once
Some parents worry that giving several vaccines at a single visit could overwhelm a child’s immune system and trigger autism. Two well-designed epidemiological studies and a meta-analysis specifically examined this concern and found no association between simultaneous vaccination and autism. A 2013 report from the Institute of Medicine, the most comprehensive review of the childhood immunization schedule at the time, uncovered no evidence of major safety concerns related to the recommended schedule.
Children’s immune systems encounter millions of foreign particles every day from food, air, and normal contact with their environment. The antigens in vaccines represent a tiny fraction of that daily exposure. Getting multiple vaccines on the same day does not create an unusual burden on a child’s immune system.
Why the Timing Creates Confusion
Autism symptoms typically become noticeable during the same developmental window when children receive many of their vaccines. A meta-analysis of 28 studies found that the average age of developmental regression in children with autism is around 20 months. This falls squarely in the period when children receive doses of several vaccines. The overlap in timing is coincidental, not causal, but it understandably leads some parents to draw a connection between a recent vaccine and the first signs of autism.
Studies that have directly tested whether immunizations trigger or correlate with regression have not found a link. Children who experience developmental regression do so at similar ages regardless of when or whether they were vaccinated.
What Actually Contributes to Autism
Autism has strong genetic roots. If one identical twin has autism, the other twin has a 60 to 90 percent chance of also having it. For non-identical twins, that drops to 0 to 24 percent. Families who already have one child with autism are about 25 times more likely than the general population to have another child on the spectrum. Roughly 10 percent of autism cases are linked to identified genetic or neurological conditions such as fragile X syndrome or tuberous sclerosis.
Several prenatal factors also play a role. Older parental age increases risk: a 10-year increase in either the mother’s or father’s age raises the likelihood of having a child with autism by 18 to 21 percent. Exposure to certain medications during pregnancy, particularly the anti-seizure drug valproate, shows a strong association with autism. Use of certain antidepressants (SSRIs) during pregnancy has been linked to a roughly 50 percent increase in risk, though this relationship is still being studied since the underlying depression itself may be a contributing factor.
The genetics of autism involve variations in genes that control how brain cells communicate with each other, particularly at the junctions (synapses) where nerve cells connect. Many of these genetic differences are present from conception, long before any vaccine is given.